Related Experiment Video
Updated: Jan 5, 2026

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
Published on: October 25, 2024
Dimeric benzoboroxoles for targeted activity against Mycobacterium tuberculosis
Collette S Guy1, Kathryn Murray, Matthew I Gibson
1School of Life Sciences, University of Warwick, CV4 7AL, UK. e.fullam@warwick.ac.uk.
None:
Dimeric benzoboroxoles that are covalently linked by a short scaffold enhance selective anti-tubercular activity. These multimeric benzoboroxole compounds are capable of engaging the specific extracellular Mycobacterium tuberculosis glycans, do not lead to the evolution of resistance and bypass the need to cross the impermeable mycobacterial cell envelope barrier.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene

